Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : L-Histidine
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 13, 2018
Lead Product(s) : L-Histidine
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Essential Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 07, 2012
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Essential Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Jazz Pharmaceuticals | Association AIRE
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Jazz Pharmaceuticals | Association AIRE
Deal Size : Inapplicable
Deal Type : Inapplicable